Think Surgical’s TMINI miniature robotic system has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for use with Zimmer Biomet’s Persona knee system.
 
This makes Think Surgical the only company at present with a robotic system that has both an implant-exclusive option with the Persona knee and an open platform for implants from multiple other manufacturers for total knee replacement.
 
The company also boasted that the strategy supports two distinct customer segments: one that prefers an open platform where a range of implants can be chosen, and another that prefers an exclusive option with the Persona knee.
 
The Persona knee, which launched in 2021, is the first implantable device approved to collect data on an individual’s progress after a total knee replacement—vital information securely relayed to a cloud-based platform for the orthopedic surgeon to review.
 
Last week, the company also began a partnership with Medacta to support its GMK Sphere and GMK SpheriKA knee implants on the TMINI miniature robotic system. Earlier this summer, Think Surgical won an FDA nod for its TMINI 1.1 system software as well.
 
“TMINI addresses surgeon demand for ergonomic, wireless, handheld robotic systems and we believe this will accelerate adoption of robotics in knee procedures, particularly in the out-patient setting,” said Think Surgical’s CEO, Stuart Simpson.

Learn more about Think Surgical and other “hot prospect” orthopedic companies that captured the ODT editors’ attention here!